SpentaGen is dedicated to accelerating the journey from target identification to effective therapy. Our integrated drug discovery platform combines computational screening, chemical biology, and pharmacology to identify and optimize lead compounds. We also specialize in advanced drug delivery systems, including nanoparticles, liposomes, and targeted carriers that improve bioavailability and reduce side effects. Through our expertise in nanomedicine, we strive to overcome biological barriers and deliver therapeutics precisely where they are needed — ultimately enhancing treatment outcomes for patients with complex diseases
Biologics & Peptide Therapeutics
Development of protein-based drugs, antibodies, and peptides as highly specific therapeutic agents.
Formulation Development & Scale-Up
Optimizing drug formulations (e.g., stability, solubility) and scaling up manufacturing processes for clinical and commercial use.
Translational Nanomedicine & Clinical Trials
Bridging nanomedicine research from bench to bedside, including preclinical studies, regulatory pathways, and clinical trial design.
Targeted & Stimuli-Responsive Nanocarriers
Nanocarriers functionalized with ligands for active targeting or designed to release drugs in response to specific stimuli (e.g., pH, temperature, enzymes).
